Go To TTD's Pre-Market Opening Breakout Watch Stock Lists Monday, March 3 |
Go to Video Show - "How to Make Money With Breakout Stocks" |
Go to Video Show - "How to Make Money With Breakout Stocks" |
---|
By Leo Fasciocco -- TTD
Ticker Tape Digest presents its daily breakout and Short Selling report. It contains Breakout Stocks and Stocks under Significant Accumulation.
Data is from tape action for the day. These stocks are most suitable for aggressive investors seeking ideal entry points for leading stocks.
These stocks will do very well during bull markets and strong market rallies.
TTD also presents Stocks To Sell or Sell Short. These issues are suitable for aggressive investors willing to take short positions both as trades or for longer-term plays. These stocks
will do very well during bear markets or market corrections
TTD's multi-media updates include a slide-show that presents charts and analysis at midsession. Some times TTD presents feature analysis on stocks and the market. TTD uses Windows Media Files. (WMV).
TTD also presents a "Breakout Watch List" that is up dated daily. This list consists of key stocks in position to breakout. A close watch of this list can put you in the stock just as it breaks out.
TTD often suggests using stop buy orders to enter. It is very important to buy a breakout stock as close as possible to the break point. The idea is to get "elbow room" if the stock should follow through to the upside. This is very important in being successful in making big money with breakout stocks.
TTD also has special feature sections on Educational Tips on Investing.
To email Mr. Leo Fasciocco leo@tickertapedigest.com.For service, email Beverly Owen owen@tickertapedigest.com. TTD’s Tel: 1-480-926-1680.
Total Buy Breakouts so far today - 3
Stocks Screened - 8,200
Bull side - Only a few breakouts today. Bulls be conservative.
Long-Term Environment for bulls: Neutral
Market Status (Daily) - NYSE Bearish, Nasdaq Bearish
Market Status (Weekly) -NYSE Bullish, Nasdaq Bearish
CDE, based in Coeur d'Alene, Idaho, produces gold and silver. Annual revenues: $222 million. CDE breaks out today from a 10-week, cup-and-handle base and makes a new 52-week high. The stock is one of the few breakouts today. Trading CDE is running at 23.7 million shares, about double its normal daily volume of 9.1 million shares. CDE is part of the strong acting gold and silver sector.
The stock got off to a strong start in the morning as the tape showed a big block of 100,000 shares crossing on a nice up tick to $4.96 from the prior trade at $4.95.
The stock was able to work its way higher even though the stock market spent the day in the red.
TTD highlighted CDE as a breakout at our midsession show on the web.
CDE's primary properties are the Silver Valley mine in Idaho and the Rochester mine in Nevada. It also has two mines in Chile and Argentina. The company is also developing mines in Bolivia and Alaska. Almost all of CDE's annual production of nearly 15 million ounces of minerals is in primary silver.
Silver has become one of the world's most vital and indispensable metal. It plays a vital role in the development of new technologies.
Silver is being used for its unique bacteria-fighting qualities. It is being used for critical healing conditions ranging from severe burns to Legionnaires Disease. The most powerful treatment for burns is silver sulfadiazine, which is used in every hospital in North America to promote healing and reduce infection.
Silver is also being used for surgical threads, bandages and dressings.
Silver is also considered one of the best electrical conductors of all metals. It does not corrode. A fully-equipped automobile may have over 40 silver-tipped switches to start the engine, activate power steering, brakes, windows, mirrors, locks and other electrical accessories.
TTD's daily chart shows the stock's solid up trend the past six months from 3.50 to 5. The subsequent basing work was well defined as a cup-and-handle set up.
The breakout today comes with a nice expansion in volume. TTD sees that as the key for the stock's potential to move higher.
The stock's TTD momentum indicator is bearish. We see that as a caution sign to be very watch of the stock's action now as it tries to follow through on the breakout.
CDE has a big plus going for it in that earnings growth this year and next will be very strong.
This year, analysts expect CDE's earnings to surge 145% to 32 cents a share from 13 cents a year ago. So, the stock sells with a price-earnings ratio of 16.
Normally, that would be okay for a metal stock. However, earnings for 2009 are expected to climb another 87% to 60 cents a share. So, based on 2009, net the stock sells with a p/e ratio of just 8.
CDE is benefiting from the high price for precious metals. For the upcoming first quarter, analysts expect net to be flat at 5 cents a share. However, for the second quarter net should increase 50% to 6 cents a share from 4 cents a year ago.
Strategy Opinion: CDE is a "special situation breakout stock." It has the benefit of good near-term technicals, strong earnings outlook and is part of a strong industry group. TTD is targeting CDE for a move to 6.50 to 7 within the next few weeks. A protective stop can be placed near 4.75. TTD rates CDE more of a trading play.
Sponsorship: Good. There have been some key buyers lately. Fidelity Low-Priced Stock Fund, 4-star rated, was a recent buyer of 1.6 million shares and 3-star rated Vanguard Small Cap Index Fund picked up 1.3 million shares.
Insider Activity: Slightly Bullish. Some modest insider buying in recent months. Six analysts follow the stock, 4 have a buy, up from 3 three months ago.
TTD's Breakout Profile
Rating Coeur D'alene Mines Corp. (CDE) |
TTD Check List | Bullish | Bearish | Neutral |
Near 52-week High | YES | ||
Volume Expansion | YES | ||
Tick Volume | YES | ||
Price Trend - Daily | YES | ||
Price Trend - Long Term | YES | ||
Price Daily Spread | YES | ||
Base Structure | YES | ||
Base - A-D | YES | ||
Earnings-Quarterly | YES | ||
Earnings-Long Term | YES | ||
Earnings Outlook | YES | ||
Industry Group | YES | ||
Prior Breakout Success | YES | ||
Fund Sponsorship | YES | ||
Total Score | 9 | 1 | 4 |
(The “breakout List” gives all stocks breaking out of a base of five weeks or more. These stocks have a good chance to trend higher. However, a stop should be used to avoid those that do not work.
(Trading strategy: One should buy breakout stocks at breakpoint by using market order or stop buy)
Charts of Breakout Stocks
Ticker Tape Digest’s Daily List of “Stocks To Sell or Sell Short” ranks stocks well timed to be sold immediately based on daily trading. The list can be used as an alert to reduce current long-term positions.
Shorts from tape action so far today - 7
Stocks Screened - 8,200
Long-Term Environment for bears: Neutral
Bear Side - Small list of breakdowns today even though stock market works lower. Bears remain venturesome.
(Trading strategy: These stocks can be sold short, or if held should be sold. If a stock is sold short, a protective stop buy should be placed. Short plays work best when the stock market is in a down trend.)
DVA, based near Los Angeles, provides dialysis services for patients suffering from chronic kidney failure. Annual revenues: $5.2 billion. DVA breaks to the downside undercutting key support today on expanding volume. TTD sees the action as triggering a bear signal. DVA will be showing a slowdown in earning the next two quarters. So far today, DVA is trading 1.2 million shares. The stock's average daily volume is 1.1 million shares.
There was no specific news to set off the stock's drop today. TTD's table shows the big block trades for Monday. The key trade was a block of 28,200 shares which went off at $49.14 near the opening. That sent the stock South.
DVA provides dialysis and other services to about 96,000 patients through 1,233 outpatient dialysis facilities in 41 states.
The company provides inpatient dialysis services at about 800 hospitals nationwide. The company also owns and operates its hospital-based dialysis services as freestanding dialysis facilities. Its DaVita Clinical Research subsidiary conducts clinical trials for devices and drugs in the renal-related area..
This year, analysts expect DVA to show just a 7% increase in net to $3.43 a share from $3.22 a year ago. Net for the upcoming first quarter should be up 9%, but then for the second quarter just be flat.
TTD's chart shows the classic down trend of the stock and today's breakdown on modestly expanding volume. The stock's TTD momentum indicator is now bearish again. TTD is targeting DVA for a decline 40 within the next few months.
TTD columnist Leo Fasciocco has covered the stock market for over 20 years. His articles appear in many publications. He is also a speaker at the Intershow conferences. He has been on television and radio. He is author of many educational articles about stock investing and the book “Guide To High-Performance Investing.”
For information to subscribe to the Ticker Tape Digest Services call: B. J. Owen at 1-480-926-1680. Distributed by Corona Publishing Enterprises. Ticker Tape Digest Inc. P.O. Box 2044 Chandler, Az. 85244-2044. TTD “Professional Report” is available on the World Wide Web: $100 per month. Password needed. “TTD Professional“ Faxed is $200 per month. The TTD Daily Report is $39.95. Credit cards accepted.
(The information contained has been prepared from data deemed reliable but there is no guarantee of complete accuracy. Ticker Tape Digest Inc. is not affiliated with any broker, dealer or investment advisor. Nothing in this publication constitutes an offer, recommendation or solicitation to buy or sell any securities. Further research is advised. This report is copyrighted and no redistribution is permitted with out permission. Some of the charts are from Telescan, Insight Trading, First Alert and other sources.)